Home | Publications | Country | Europe (West) | Switzerland place holder
place holder place holder

Switzerland

NRT Smoking Cessation Aids in Switzerland


Publication Date   June 2006
Publisher   Euromonitor International
Product Type   Report
Pages   28
ISBN Number   not applicable
Product Code   EUR594
Ask a question about this product?

Price £450.00

approximately: $841 | €571

Summary


Smoking Cessation Aids in Switzerland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2000-2005), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2010 illustrate how the market is set to change.

Product coverage:

NRT gum, NRT patches, NRT inhalators, other

Data coverage:

market sizes (historic and forecasts), company shares, brand shares

Why buy this report?

  • Get a detailed picture of the smoking cessation aids industry
  • Pinpoint growth sectors and trends and identify factors driving change
  • Understand the competitive environment, the market's major players and leading brands
  • Use five-year forecasts to assess how the market is predicted to develop

Content


NRT Smoking Cessation Aids in Switzerland

1. EXECUTIVE SUMMARY

2. OPERATING ENVIRONMENT

2.1 OTC Registration and Classification
2.2 Vitamins & Dietary Supplements Registration and Classification
2.3 Advertising
2.4 Packaging and Labelling
2.5 Distribution
2.6 De-listing or De-reimbursement
2.7 Traditional Remedies
2.8 Homeopathy
2.9 Generics
2.10 Consumer Expenditure on Health Goods and Medical Services
Table 1 Consumer Expenditure on Health Goods and Medical Services 2000-2005
2.11 Life Expectancy
Table 2 Life Expectancy at Birth 2000-2005

3. OTC HEALTHCARE SALES

3.1 Market Performance
Table 3 Sales of OTC Healthcare by Sector: Value 2000-2005
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2000-2005
3.2 Switches
Summary 1 OTC Healthcare Switches 2004-2005
3.3 Competitive Environment
Table 5 OTC Healthcare Company Shares by Retail Value 2001-2005
Table 6 OTC Healthcare Brand Shares by Retail Value 2002-2005
3.4 Leading Company Profile: Bioforce AG
Summary 2 Bioforce AG: Operational Indicators 2004
3.5 Leading Company Profile: Galenica Holding AG
Summary 3 Galenica Holding AG: Operational Indicators 2004
3.6 Leading Company Profile: Novartis Consumer Health Schweiz AG
Summary 4 Novartis Consumer Health Schweiz AG: Operational Indicators 2004
3.7 Leading Company Profile: Spirig Pharma AG
3.8 Retail Distribution
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2000/2005
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2005
3.9 Retailer Activity and Private Label Trends
Table 9 Penetration of Private Label by Sector 2001-2005
3.10 Forecast Market Performance
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2005-2010
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2005-2010

4. NRT SMOKING CESSATION AIDS SALES

4.1 Number of Smokers
Table 12 Number of Smokers by Gender 2000-2005
4.2 Sector Performance
Table 13 Sales of NRT Smoking Cessation Aids by Subsector: Value 2000-2005
Table 14 Sales of NRT Smoking Cessation Aids by Subsector: % Value Growth 2000-2005
Table 15 NRT Smoking Cessation Aids Company Shares by Retail Value 2001-2005
Table 16 NRT Smoking Cessation Aids Brand Shares by Retail Value 2002-2005
Table 17 Forecast Sales of NRT Smoking Cessation Aids by Subsector: Value 2005-2010
Table 18 Forecast Sales of NRT Smoking Cessation Aids by Subsector: % Value Growth 2005-2010

5. DEFINITIONS